Michael Sardano, PRESIDENT AND GENERAL COUNSEL at Sensus Healthcare, Inc. (SRTS), bought 234 shares at $4.24 ($992) on 2025-11-11, disclosed to the SEC on 2025-11-13.
Open-market purchase of $992 SRTS by PRESIDENT AND GENERAL COUNSEL. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| SRTS | BUY | 2025-08-14 | $3K | — | Filing → |
| SRTS | BUY | 2025-02-10 | $6K | — | Filing → |
| SRTS | BUY | 2023-08-28 | $3K | — | Filing → |